These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32971150)

  • 1. Incidence of COVID-19 infection and prevalence of diabetes, obesity and hypertension according to altitude in Peruvian population.
    Seclén SN; Nunez-Robles E; Yovera-Aldana M; Arias-Chumpitaz A
    Diabetes Res Clin Pract; 2020 Nov; 169():108463. PubMed ID: 32971150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between obesity and diabetes prevalence and COVID-19 mortality in Mexico: an ecological study.
    Noyola DE; Hermosillo-Arredondo N; Ramírez-Juárez C; Werge-Sánchez A
    J Infect Dev Ctries; 2021 Oct; 15(10):1396-1403. PubMed ID: 34780361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
    Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
    Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19, Non-Communicable Diseases, and Behavioral Factors in the Peruvian Population ≥ 15 Years: An Ecological Study during the First and Second Year of the COVID-19 Pandemic.
    Canorio J; Sánchez F; Ramírez-Soto MC
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36142027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report.
    Conway J; Gould A; Westley R; Raju SA; Oklopcic A; Broadbent A; Abdelhafiz AH; Sinclair AJ
    Diabetes Res Clin Pract; 2020 Nov; 169():108460. PubMed ID: 32971153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
    Shah H; Khan MSH; Dhurandhar NV; Hegde V
    Acta Diabetol; 2021 Jul; 58(7):831-843. PubMed ID: 33587177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological study of hypertension in natives of Spiti Valley in Himalayas and impact of hypobaric hypoxemia; a cross-sectional study.
    Negi PC; Bhardwaj R; Kandoria A; Asotra S; Ganju N; Marwaha R; Sharma R; Kanwar A
    J Assoc Physicians India; 2012 Jun; 60():21-5. PubMed ID: 23409416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture.
    Luzi L; Carruba M; Crialesi R; Da Empoli S; Dagani R; Lovati E; Nicolucci A; Berra CC; Cipponeri E; Vaccaro K; Lenzi A
    Acta Diabetol; 2021 Jul; 58(7):919-927. PubMed ID: 33740123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?
    Markus B; Kreutz J; Schieffer B
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320963929. PubMed ID: 33040679
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France.
    Hoang VT; Colson P; Levasseur A; Delerce J; Lagier JC; Parola P; Million M; Fournier PE; Raoult D; Gautret P
    Infect Genet Evol; 2021 Nov; 95():105092. PubMed ID: 34571275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients.
    Leon-Abarca JA; Portmann-Baracco A; Bryce-Alberti M; Ruiz-Sánchez C; Accinelli RA; Soliz J; Gonzales GF
    PLoS One; 2021; 16(8):e0255144. PubMed ID: 34343179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
    Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
    Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave.
    Sharif N; Opu RR; Ahmed SN; Sarkar MK; Jaheen R; Daullah MU; Khan S; Mubin M; Rahman H; Islam F; Haque N; Islam S; Khan FB; Haque N; Ayman U; Shohael AM; Dey SK; Talukder AA
    Diabetes Metab Syndr; 2021; 15(4):102148. PubMed ID: 34186349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia.
    Kirillov Y; Timofeev S; Avdalyan A; Nikolenko VN; Gridin L; Sinelnikov MY
    J Prim Care Community Health; 2021; 12():21501327211008050. PubMed ID: 33829916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in COVID-19 incidence and fatality rates at high-altitude.
    Abbasi BA; Chanana N; Palmo T; Pasha Q
    PeerJ; 2023; 11():e14473. PubMed ID: 36788813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.
    Buscemi S; Corleo D; Randazzo C
    Adv Exp Med Biol; 2021; 1353():115-129. PubMed ID: 35137371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Protective Effect from COVID-19 Conferred by Altitude: A Longitudinal Analysis in Peru During Full Lockdown.
    Thomson TM; Casas F; Guerrero HA; Figueroa-Mujíca R; Villafuerte FC; Machicado C
    High Alt Med Biol; 2021 Jun; 22(2):209-224. PubMed ID: 33780636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude?
    Arias-Reyes C; Zubieta-DeUrioste N; Poma-Machicao L; Aliaga-Raduan F; Carvajal-Rodriguez F; Dutschmann M; Schneider-Gasser EM; Zubieta-Calleja G; Soliz J
    Respir Physiol Neurobiol; 2020 Jun; 277():103443. PubMed ID: 32333993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.